Health Systems Strengthening Project Impact Evaluation 2015, Baseline Survey
Liberia, 2013 - 2015
Get MicrodataCreated on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
226918
Q106: H. Other (specify) (q106h_spec)
Data file: p_v_3
Overview
Valid:
35
Invalid:
0
Type:
Discrete
Start:
888
End:
937
Width:
50
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ACT | 2 |
5.7%
|
|
| ACT,PCM | 1 |
2.9%
|
|
| ANTI MALARIA DRUG (ACT& QUININE) | 1 |
2.9%
|
|
| ANTI-MALARIA IF LAB RESULT IS POSITIVE | 1 |
2.9%
|
|
| ANTIMALARIA,FEVER,PCM | 1 |
2.9%
|
|
| ANTIMALARIA,PARACETEMAL | 1 |
2.9%
|
|
| ANTIMALARIA,PCM | 1 |
2.9%
|
|
| D50% | 1 |
2.9%
|
|
| ESTABLISH IV LINE AND ADMINISTER R/L | 1 |
2.9%
|
|
| ESTABLISH IV LINE,ADMINISTER R/L,ANTIMALARIA ACT | 1 |
2.9%
|
|
| IV FLUID | 1 |
2.9%
|
|
| IV FLUID TILL CHILD TOLERATE MEDICATIO BY MONTH | 1 |
2.9%
|
|
| IV FLUID TO CORRECT DEHYDRATION | 1 |
2.9%
|
|
| IV LINE ESTABLISH | 1 |
2.9%
|
|
| METOCLOPRAMIDE, R/L TO CORRECT DEHYDRATION | 1 |
2.9%
|
|
| METODOPRAMIDE TO STOP VOMITING | 1 |
2.9%
|
|
| MULTI-VITAMIN,ZINC,SULFATE | 1 |
2.9%
|
|
| PARACETEMOL | 1 |
2.9%
|
|
| PCM | 2 |
5.7%
|
|
| PCM 100MG BID X 3 | 1 |
2.9%
|
|
| PCM 100MG, | 1 |
2.9%
|
|
| PCM, FESO4 | 1 |
2.9%
|
|
| PCM,MULTIVITAMIN,VERMOX | 1 |
2.9%
|
|
| PCM,ZINC | 1 |
2.9%
|
|
| PERACETAMOL | 1 |
2.9%
|
|
| R/L INFUSION | 1 |
2.9%
|
|
| RIL,ZINC | 1 |
2.9%
|
|
| VERMOX | 1 |
2.9%
|
|
| ZINC | 3 |
8.6%
|
|
| ZINC SULFATE, PCM,MULTI V, IV FLUID | 1 |
2.9%
|
|
| ZINC SULPHATE | 1 |
2.9%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.